论文部分内容阅读
应用ELISA法对76例各类肝病患者血清进行抗－HCV检测，结果抗－HCV阳性率为21．1％。在急性肝炎、慢性肝炎、肝硬化和肝癌中，抗－HCV阳性率分别为0、7．7％、36．1％和16．7％。抗－HCV阳性率有随肝病慢性化而增高的趋势，肝硬化的抗－HCV阳性率明显高于急性肝炎（X2＝6．35P＜0．05），其他各类肝病患者的抗－HCV阳性率差异无显著性（P＞0．05）。同时发现HBsAg阴性的肝病患者的抗－HCV阳性率高于HBsAg阳性患者，但差异无显著性（X2＝3．10P＞0．05）
Anti-HCV was detected by ELISA in sera of 76 patients with various liver diseases. The positive rate of anti-HCV was 21.1%. In acute hepatitis, chronic hepatitis, cirrhosis and liver cancer, the positive rates of anti-HCV were 0, 7%, 36.1% and 16.7%, respectively. The positive rate of anti-HCV with the trend of chronic liver disease increased, anti-HCV positive rate of cirrhosis was significantly higher than acute hepatitis (X2 = 6.35P <0.05), other types of liver disease in patients with anti-HCV positive The difference was not significant (P> 0.05). At the same time, the positive rate of anti-HCV in patients with HBsAg-negative liver disease was higher than that in HBsAg-positive patients, but the difference was not significant (X2 = 3.10P> 0.05)